First Header Logo Second Header Logo

Randolph Geary

Concepts (290)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Muscle, Smooth, Vascular
6
2013
63
1.040
Why?
Myocytes, Smooth Muscle
4
2013
72
0.770
Why?
Carotid Arteries
6
2013
99
0.630
Why?
Blood Vessel Prosthesis
4
2012
83
0.600
Why?
Tunica Intima
5
2005
57
0.540
Why?
Endothelial Cells
5
2012
189
0.530
Why?
Extracellular Matrix Proteins
1
2013
45
0.440
Why?
RGS Proteins
4
2007
18
0.440
Why?
Hyaluronic Acid
1
2013
52
0.430
Why?
Carotid Stenosis
1
2013
58
0.430
Why?
Tissue Scaffolds
4
2012
415
0.380
Why?
Tissue Engineering
3
2012
656
0.360
Why?
Stem Cells
2
2010
313
0.350
Why?
Stents
3
2009
177
0.320
Why?
Blood Vessels
2
2008
48
0.310
Why?
Arteriosclerosis
3
2004
123
0.310
Why?
Venous Thrombosis
3
2019
49
0.300
Why?
Blood Vessel Prosthesis Implantation
3
2012
69
0.270
Why?
Cells, Cultured
6
2013
834
0.270
Why?
Animals
13
2020
7542
0.250
Why?
Gene Expression Profiling
2
2005
322
0.250
Why?
Iliac Artery
2
2002
49
0.250
Why?
Enzyme Inhibitors
2
2004
166
0.240
Why?
Catheterization
2
2019
58
0.240
Why?
Popliteal Vein
2
2019
3
0.240
Why?
Femoral Vein
2
2019
9
0.240
Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
1
2004
2
0.230
Why?
Protein-Serine-Threonine Kinases
1
2004
50
0.230
Why?
Renal Dialysis
2
2019
282
0.220
Why?
Hyperplasia
3
2013
41
0.220
Why?
Time Factors
8
2013
2151
0.220
Why?
Cell Adhesion
3
2013
108
0.210
Why?
Genes
1
2002
15
0.210
Why?
Oligonucleotide Array Sequence Analysis
1
2002
160
0.210
Why?
Metalloendopeptidases
1
2002
11
0.200
Why?
Hydroxamic Acids
1
2002
21
0.200
Why?
Jugular Veins
2
2012
26
0.190
Why?
Neovascularization, Physiologic
1
2002
110
0.190
Why?
Arteriovenous Shunt, Surgical
2
2012
48
0.190
Why?
Coated Materials, Biocompatible
1
2020
18
0.180
Why?
Drug Carriers
1
2020
21
0.180
Why?
Aorta
3
2007
126
0.180
Why?
Keratosis
1
2020
23
0.180
Why?
Vascular Surgical Procedures
3
2013
88
0.170
Why?
Sheep
5
2012
233
0.170
Why?
Biomedical Research
2
2013
156
0.170
Why?
Drug Delivery Systems
1
2020
104
0.160
Why?
Collagen Type I
2
2013
42
0.160
Why?
Patient Selection
2
2019
276
0.160
Why?
Thrombolytic Therapy
1
2019
63
0.160
Why?
Vascular Diseases
2
2013
66
0.160
Why?
Prosthesis Design
4
2012
97
0.150
Why?
Cardiovascular Agents
2
2020
23
0.150
Why?
Renal Artery Obstruction
2
2009
41
0.150
Why?
Macaca fascicularis
3
2004
434
0.150
Why?
Mice, Inbred C57BL
2
2013
767
0.140
Why?
Pulsatile Flow
3
2012
26
0.140
Why?
Bioreactors
3
2012
60
0.130
Why?
Renal Artery
2
2006
47
0.130
Why?
Collagen
2
2008
225
0.130
Why?
Antineoplastic Agents
1
2020
608
0.120
Why?
Tyrosine
2
2004
23
0.120
Why?
Kidney Failure, Chronic
1
2019
543
0.120
Why?
Angioplasty, Balloon
2
2020
35
0.110
Why?
Stress, Mechanical
2
2012
92
0.110
Why?
Cell Shape
1
2013
28
0.110
Why?
Graft Occlusion, Vascular
2
2012
24
0.110
Why?
Lipoproteins, HDL
2
2007
251
0.110
Why?
Mice
2
2013
2484
0.110
Why?
Health Priorities
1
2013
15
0.110
Why?
Comparative Effectiveness Research
1
2013
25
0.110
Why?
Rats
3
2013
1596
0.110
Why?
Cell Culture Techniques
2
2012
173
0.100
Why?
Recurrence
1
2013
263
0.100
Why?
Materials Testing
2
2012
89
0.100
Why?
Cell Movement
1
2013
169
0.100
Why?
Anticoagulants
2
2019
122
0.100
Why?
Male
14
2019
19217
0.100
Why?
Vascular Patency
5
2012
69
0.100
Why?
Coronary Artery Disease
2
2007
401
0.100
Why?
Mice, Knockout
1
2013
443
0.100
Why?
Blotting, Western
2
2010
289
0.100
Why?
Societies, Medical
1
2013
164
0.100
Why?
Stem Cell Transplantation
2
2012
209
0.100
Why?
Signal Transduction
2
2013
682
0.100
Why?
Vasoconstriction
2
2011
43
0.100
Why?
Hemodynamics
1
2012
155
0.100
Why?
RNA, Messenger
4
2007
508
0.100
Why?
Female
13
2019
20015
0.100
Why?
Rats, Sprague-Dawley
1
2013
743
0.090
Why?
Cell Proliferation
2
2010
604
0.090
Why?
Bioprosthesis
1
2011
58
0.090
Why?
Intramolecular Oxidoreductases
1
2010
6
0.090
Why?
Cytochrome P-450 Enzyme System
1
2010
27
0.090
Why?
Nitric Oxide Synthase Type III
1
2010
36
0.090
Why?
Immunohistochemistry
4
2020
538
0.090
Why?
Hypertension
3
2007
960
0.080
Why?
Clinical Medicine
1
2009
12
0.080
Why?
Angioplasty
1
2009
34
0.080
Why?
Disease Models, Animal
1
2013
1022
0.080
Why?
Swine
1
2010
215
0.080
Why?
Polyesters
1
2008
76
0.080
Why?
Constriction, Pathologic
2
2012
46
0.080
Why?
Regional Blood Flow
2
2012
86
0.080
Why?
Peroxidase
2
2004
31
0.070
Why?
Myosin Heavy Chains
2
2011
89
0.070
Why?
Arteries
2
2004
67
0.070
Why?
Vena Cava Filters
1
2007
13
0.070
Why?
Complement Activation
1
2007
9
0.070
Why?
Peptide Hydrolases
1
2007
17
0.070
Why?
Prosthesis Implantation
1
2007
40
0.070
Why?
Down-Regulation
2
2004
142
0.070
Why?
Humans
17
2019
32114
0.070
Why?
Vena Cava, Inferior
1
2007
30
0.070
Why?
Device Removal
1
2007
33
0.070
Why?
Iliac Vein
1
2006
8
0.070
Why?
Pancreatitis, Acute Necrotizing
1
2006
8
0.070
Why?
Proteomics
1
2007
94
0.070
Why?
Follow-Up Studies
4
2019
2265
0.070
Why?
Balloon Occlusion
1
2006
36
0.070
Why?
Thrombectomy
1
2006
74
0.070
Why?
Dose-Response Relationship, Drug
2
2004
633
0.060
Why?
Carboxypeptidases
1
2005
21
0.060
Why?
Middle Aged
9
2019
11839
0.060
Why?
Viscera
1
2004
17
0.060
Why?
Receptor, Angiotensin, Type 1
1
2005
65
0.060
Why?
Hypochlorous Acid
1
2004
2
0.060
Why?
Carotid Artery Diseases
1
2005
114
0.060
Why?
Aged
8
2019
10314
0.060
Why?
Reactive Nitrogen Species
1
2004
5
0.060
Why?
Phenotype
2
2005
632
0.060
Why?
Arterial Occlusive Diseases
1
2004
35
0.060
Why?
Aorta, Thoracic
1
2005
85
0.060
Why?
Intestine, Small
1
2004
40
0.060
Why?
Aneurysm
1
2004
21
0.060
Why?
ATP-Binding Cassette Transporters
1
2004
60
0.060
Why?
rho-Associated Kinases
1
2004
7
0.060
Why?
Ischemia
1
2004
98
0.060
Why?
Gels
1
2004
31
0.060
Why?
Cholesterol, HDL
1
2004
177
0.060
Why?
Anoikis
1
2003
2
0.060
Why?
Tropomyosin
1
2003
3
0.060
Why?
Intracellular Signaling Peptides and Proteins
1
2004
73
0.060
Why?
Myocardium
1
2004
186
0.060
Why?
Embolism
1
2003
6
0.050
Why?
Coronary Vessels
1
2004
165
0.050
Why?
Drosophila Proteins
1
2003
45
0.050
Why?
Angiotensin I
1
2005
241
0.050
Why?
RNA, Ribosomal, 28S
1
2002
1
0.050
Why?
Mesenteric Vascular Occlusion
1
2003
12
0.050
Why?
Versicans
1
2002
4
0.050
Why?
Venae Cavae
1
2002
4
0.050
Why?
Blotting, Northern
1
2002
31
0.050
Why?
In Situ Hybridization
1
2002
38
0.050
Why?
Lectins, C-Type
1
2002
13
0.050
Why?
Retrospective Studies
6
2009
3510
0.050
Why?
Carcinoma
1
2003
91
0.050
Why?
Thrombosis
1
2003
73
0.050
Why?
Peptide Fragments
1
2005
399
0.050
Why?
Treatment Outcome
4
2019
3306
0.050
Why?
Aortic Aneurysm, Abdominal
1
2002
49
0.050
Why?
Kidney Diseases
1
2004
249
0.050
Why?
Mass Spectrometry
3
2007
102
0.050
Why?
Adult
6
2019
9380
0.050
Why?
Kidney
1
2004
518
0.040
Why?
Drug Evaluation, Preclinical
1
2020
62
0.040
Why?
Paclitaxel
1
2020
67
0.040
Why?
Atherosclerosis
1
2006
766
0.040
Why?
Catheter-Related Infections
1
2019
10
0.040
Why?
Risk Assessment
2
2019
1429
0.040
Why?
Postthrombotic Syndrome
1
2019
1
0.040
Why?
Stockings, Compression
1
2019
2
0.040
Why?
Fibrinolysis
1
2019
7
0.040
Why?
Thromboembolism
1
2019
34
0.040
Why?
Catheterization, Peripheral
1
2019
29
0.040
Why?
Forecasting
1
2019
143
0.040
Why?
Fibrinolytic Agents
1
2019
70
0.040
Why?
Hemorrhage
1
2019
100
0.040
Why?
Brain
1
2004
951
0.040
Why?
Patient Compliance
1
2019
225
0.040
Why?
Breast Neoplasms
1
2003
765
0.040
Why?
Chromatography, Liquid
2
2007
43
0.030
Why?
Postoperative Complications
3
2006
780
0.030
Why?
Amino Acid Sequence
2
2007
285
0.030
Why?
Molecular Sequence Data
2
2007
359
0.030
Why?
Severity of Illness Index
2
2009
881
0.030
Why?
Tomography, X-Ray Computed
2
2012
919
0.030
Why?
Incidence
2
2009
1199
0.030
Why?
Cardiovascular Diseases
1
2002
1128
0.030
Why?
Survival Rate
2
2009
877
0.030
Why?
Organizational Objectives
1
2013
23
0.030
Why?
Research Support as Topic
1
2013
26
0.030
Why?
Ultrasonography, Doppler, Pulsed
1
2012
6
0.030
Why?
Quality of Life
1
2019
946
0.030
Why?
Angiography, Digital Subtraction
1
2012
19
0.030
Why?
Ultrasonography, Doppler, Color
1
2012
19
0.030
Why?
Equipment Failure Analysis
1
2012
42
0.030
Why?
Punctures
1
2012
33
0.030
Why?
Needles
1
2012
31
0.030
Why?
Prosthesis Failure
1
2012
45
0.030
Why?
Diagnostic Imaging
1
2013
94
0.030
Why?
Inflammation
2
2007
530
0.030
Why?
Models, Animal
1
2012
169
0.020
Why?
Young Adult
1
2019
2665
0.020
Why?
Feasibility Studies
1
2012
294
0.020
Why?
Actins
1
2011
51
0.020
Why?
Carotid Artery, Common
1
2011
39
0.020
Why?
Coculture Techniques
1
2011
81
0.020
Why?
Femoral Artery
1
2011
50
0.020
Why?
Transplantation, Homologous
1
2011
151
0.020
Why?
Pilot Projects
1
2012
548
0.020
Why?
Vasoconstrictor Agents
1
2011
61
0.020
Why?
Adolescent
1
2019
3568
0.020
Why?
Colony-Forming Units Assay
1
2009
19
0.020
Why?
Chromatography, Affinity
1
2009
15
0.020
Why?
Hematology
1
2009
8
0.020
Why?
Ultrasonography, Doppler, Duplex
1
2009
46
0.020
Why?
Cell Count
1
2009
47
0.020
Why?
Confidence Intervals
1
2009
149
0.020
Why?
Probability
1
2009
159
0.020
Why?
Glycoproteins
1
2009
45
0.020
Why?
Angiography
1
2009
80
0.020
Why?
Platelet Adhesiveness
1
2008
14
0.020
Why?
Sex Distribution
1
2009
191
0.020
Why?
Kinetics
1
2009
209
0.020
Why?
Antigens, CD
1
2009
103
0.020
Why?
Age Distribution
1
2009
206
0.020
Why?
Peptides
1
2009
120
0.020
Why?
Hypertrophy
1
2007
27
0.020
Why?
Blood Pressure
1
2012
845
0.020
Why?
Phenylephrine
1
2007
28
0.020
Why?
Serotonin
1
2007
38
0.020
Why?
Registries
1
2009
298
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2007
263
0.020
Why?
Proportional Hazards Models
1
2009
753
0.020
Why?
Phlebography
1
2007
26
0.020
Why?
Microscopy, Electron, Scanning
1
2007
98
0.020
Why?
Medical Records
1
2007
76
0.020
Why?
Injections, Intravenous
1
2006
78
0.020
Why?
Reconstructive Surgical Procedures
1
2008
198
0.020
Why?
Lipid Metabolism
1
2007
105
0.020
Why?
Pulmonary Embolism
1
2007
49
0.020
Why?
Tunica Media
1
2005
28
0.020
Why?
Creatinine
1
2006
195
0.020
Why?
Atenolol
1
2005
6
0.020
Why?
Hydralazine
1
2005
7
0.020
Why?
Rats, Inbred SHR
1
2005
31
0.020
Why?
Glomerular Filtration Rate
1
2006
308
0.020
Why?
Tetrazoles
1
2005
61
0.020
Why?
Adrenergic beta-Antagonists
1
2005
61
0.020
Why?
Mesenteric Artery, Inferior
1
2004
2
0.020
Why?
Vasodilator Agents
1
2005
62
0.020
Why?
Angiotensin II Type 1 Receptor Blockers
1
2005
65
0.020
Why?
Mesenteric Artery, Superior
1
2004
9
0.020
Why?
Imidazoles
1
2005
91
0.020
Why?
Gene Expression Regulation, Enzymologic
1
2005
80
0.020
Why?
Peroxynitrous Acid
1
2004
7
0.020
Why?
Lipid Peroxides
1
2004
8
0.020
Why?
Taurine
1
2004
6
0.020
Why?
Nitrogen
1
2004
10
0.020
Why?
Epitopes
1
2004
24
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2004
28
0.010
Why?
Apolipoprotein A-I
1
2004
68
0.010
Why?
Peptidyl-Dipeptidase A
1
2005
132
0.010
Why?
Nitric Oxide
1
2004
111
0.010
Why?
Angiotensin II
1
2005
244
0.010
Why?
Protein Isoforms
1
2003
57
0.010
Why?
Oxygen
1
2004
142
0.010
Why?
Genes, Tumor Suppressor
1
2003
34
0.010
Why?
Survival Analysis
1
2004
483
0.010
Why?
Tumor Cells, Cultured
1
2003
171
0.010
Why?
Cell Transformation, Neoplastic
1
2003
57
0.010
Why?
Peritonitis
1
2003
14
0.010
Why?
Tumor Suppressor Proteins
1
2003
71
0.010
Why?
Nephrectomy
1
2004
123
0.010
Why?
Mesenteric Arteries
1
2003
20
0.010
Why?
Chronic Disease
1
2004
406
0.010
Why?
Multivariate Analysis
1
2004
684
0.010
Why?
Comorbidity
1
2004
566
0.010
Why?
Morbidity
1
2003
98
0.010
Why?
North Carolina
1
2007
1538
0.010
Why?
Sensitivity and Specificity
1
2003
582
0.010
Why?
Intraoperative Complications
1
2002
56
0.010
Why?
Random Allocation
1
2002
228
0.010
Why?
Gene Expression Regulation
1
2003
495
0.010
Why?
Logistic Models
1
2003
783
0.010
Why?
Length of Stay
1
2002
314
0.010
Why?
Age Factors
1
2002
1189
0.010
Why?
Risk Factors
1
2004
3880
0.010
Why?
Aged, 80 and over
1
2002
3990
0.010
Why?
Geary's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (290)
Explore
_
Co-Authors (26)
Explore
_
Similar People (53)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_